about
Molecular insights into the dynamics of pharmacogenetically important N-terminal variants of the human β2-adrenergic receptorBeta-2 adrenergic receptor (ADRB2) gene polymorphisms and the risk of asthma: a meta-analysis of case-control studies.Polymorphism profiling of nine high altitude relevant candidate gene loci in acclimatized sojourners and adapted natives.Frequencies of the Arg16Gly, Gln27Glu and Thr164Ile Adrenoceptor β2 Polymorphisms among Omanis.ADRB2 polymorphisms predict the risk of myocardial infarction and coronary artery diseaseStructural insights and functional implications of inter-individual variability in β2-adrenergic receptorADRB2 G-G haplotype associated with breast cancer risk among Hispanic and non-Hispanic white women: interaction with type 2 diabetes and obesity.Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder.Pharmacogenetics and the treatment of asthma.Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.Specificity of SNP detection with molecular beacons is improved by stem and loop separation with spacers.Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics.Pharmacogenomics and bioinformatics: PharmGKB.Association between ß2-adrenergic receptor gene polymorphisms and adverse events of ritodrine in the treatment of preterm labor: a prospective observational study.Genetic variation in human drug-related genes.Association of β(2)-adrenergic receptor polymorphisms with asthma in a North Indian population.Polymorphisms of beta2-adrenergic receptor gene in serbian asthmatic adults: effects on response to Beta-agonists.Assessment of coding region variants in Kuwaiti population: implications for medical genetics and population genomicsBeta2-Adrenergic Receptor Gene Polymorphisms in Egyptian Patients with Acute Myocardial Infarction
P2860
Q28542663-6AB66AB6-82BD-4DD8-A7BB-C7ABBA2534C2Q34028227-AF1D1290-DB56-4A08-861E-5097C47662B5Q35776631-FAF3252E-8B6E-4D5E-9672-AA5BCC361B87Q36331342-760190A0-8957-4470-B777-CCF9A1887EB8Q36606238-39A4C29C-712D-4AAD-BE6F-DC6B3F14C64EQ36796209-8999337B-5722-4930-95D5-C005C2A727A7Q37224416-2E3E2311-3AE3-4449-B8B4-C37B8FEF08D9Q37642812-82760312-0A66-4285-AC84-F26DCA061498Q38646972-C01DC50A-919C-45BF-BADE-97901D6F0E26Q38853320-F783962F-2964-479E-A9F1-36F82D1650EFQ40326440-AF2BA241-C613-4387-8CBC-FEC06AFDE1C6Q41673144-3825B44D-51AC-48FE-8758-E14476B613E6Q42654621-C6D1FA3F-9BCB-40BC-A93C-621A88024142Q46977246-54C86592-1496-435C-A039-00EF2ABAAF48Q47564586-FC658E3F-3288-44C2-949F-B2FC5B0D5EE0Q53730299-3E1B8BBA-3F0B-459F-BFBE-5B027D71808EQ54196591-040046B1-5985-4BFB-B3D6-38A6E5647F93Q58590120-DBE7DC8C-19DD-4B7F-94C9-201F7D9EF250Q59049500-CDA1F80A-6DD6-4C3E-B866-981986ED2538
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Very important pharmacogene summary ADRB2.
@ast
Very important pharmacogene summary ADRB2.
@en
Very important pharmacogene summary ADRB2.
@nl
type
label
Very important pharmacogene summary ADRB2.
@ast
Very important pharmacogene summary ADRB2.
@en
Very important pharmacogene summary ADRB2.
@nl
prefLabel
Very important pharmacogene summary ADRB2.
@ast
Very important pharmacogene summary ADRB2.
@en
Very important pharmacogene summary ADRB2.
@nl
P2093
P2860
P1476
Very important pharmacogene summary ADRB2.
@en
P2093
Jaekyu Shin
Julie A Johnson
Mariellen J Moore
Qing Ling Duan
Scott T Weiss
Teri E Klein
P2860
P356
10.1097/FPC.0B013E328333DAE6
P577
2010-01-01T00:00:00Z